Document is current
Any future updates will be listed below
-
Authors
Kahn, Steven A.
Carter, Jeffrey E.
Wilde, Shelby
Chamberlain, Aleisha
Walsh, Thomas P.
Sparks, Jeremiah A.
-
Funding
Funding for this research was provided by:
AVITA Medical
- License Information
-
More Information
Article History
Received: 20 November 2023
Accepted: 20 December 2023
First Online: 22 January 2024
Declarations
:
: Steven A. Kahn has served as a consultant to and/or speaker for AVITA Medical, Vericel Corporation, Integra Life Sciences, Medline Inc., Ex Surco, and Lumenis Inc. He has conducted research for AVITA Medical and participated on advisory panels for Vericel Corporation and Mallinckrodt. Jeffrey E. Carter is a consultant to SpectralMD Inc. and AVITA Medical. He is a stockholder of PermeaDerm Inc. & SpectralMD Inc. and has research supported by Spirit of Charity Foundation Burn Research Fund. Shelby Wilde, Aleisha Chamberlain, Thomas P. Walsh, and Jeremiah A. Sparks ae employees of AVITA Medical, Valencia, CA, USA.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
